Conagen Inc. – Trademark Portfolio
Entity Type: 03
Conagen Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CMAX, CONAMAX, BIOAMAZING, and MAKING IMPOSSIBLE POSSIBLE. The owner is based in Bedford, MA.
15 DeAngelo Drive
Bedford, MA 01730
Showing of trademarks Trademarks
Trademark Classifications
Conagen Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Conagen Inc. have?
Conagen Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 5 registered, 5 abandoned, 4 cancelled.
What trademark classes does Conagen Inc. file in?
Conagen Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Conagen Inc.'s most well-known trademarks?
Conagen Inc.'s registered trademark portfolio includes well-known marks such as CMAX, CONAMAX, BIOAMAZING, and MAKING IMPOSSIBLE POSSIBLE. These are among 5 currently registered trademarks in the portfolio.
What is Conagen Inc.'s trademark registration success rate?
Conagen Inc. has a 36% trademark registration rate, with 5 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.